Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

Dec 19, 2013

5229_dirs_2013-12-19_2b1884f3-1884-4502-9b81-4a2da027ed91.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9993V

AstraZeneca PLC

19 December 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 19 December 2013, Marc Dunoyer, a Director of the Company notified us that, on 19 December 2013, he purchased 500 AstraZeneca PLC Ordinary Shares of $0.25 each at a price of 3601 pence per share.

Under the Company's Articles of Association, by way of qualification, a Director is required to be the beneficial owner of 500 Ordinary Shares of the Company, such shares to be obtained within two months of the date of his appointment. Mr Dunoyer was appointed a Director on 1 November 2013.

Following this purchase, Mr Dunoyer has a total interest, including an interest under certain of the Company's share plans, in 165,034 AstraZeneca shares.

A C N Kemp

Company Secretary

19 December 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUKSURONAUAAA